Additionally, CD8+CD28−, CD8+PD1+, and CD8+CD28+PD1− T cell proportions in PBMC are closely associated with metabolic disorders, emphasizing their potential as biomarkers for immune and metabolic interactions in EC. The gene discussed is CD8A; the disease is Other metabolic disease.